ECZEMA

This study tested whether a moisturizer containing postbiotics (helpful yeast and bacteria) can lower the chance of eczema returning in children aged 0-6 years whose eczema was in remission. 98 children took part, and researchers tracked how many had flare-ups compared to those u…

This study tested whether a team-based online care model works as well as traditional in-person visits for managing atopic dermatitis (eczema). 300 patients were randomly assigned to either online or in-person care for 12 months. The main goal was to see if eczema severity improv…

This study tested a new medicine called camoteskimab in 62 adults with moderate to severe eczema (atopic dermatitis). The goal was to see if it could reduce skin redness, itching, and rash better than a placebo over 12 weeks. Participants received either the drug or a placebo, an…

This study tested an experimental drug, EVO301, in 71 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug safely reduces skin redness, thickness, and itch. Participants received either EVO301 or a placebo, and doctors measured changes in ski…

This study tested two creams—crisaborole and fluticasone—on 40 children aged 1 to 12 with mild to moderate eczema. Both creams were applied twice daily for 6 weeks, then twice weekly for 12 weeks if the skin improved a lot. Both treatments helped reduce itching and skin redness, …

This study looked at how dupilumab affects the immune and genetic activity inside eczema skin lesions. Seventeen adults with moderate-to-severe eczema received the drug, and researchers measured changes in immune cells and gene activity over 12 weeks. The goal was to understand h…

This study looked at a specific immune pathway (PGE2/IL22/IL17) in people with eczema to see if it plays a role in the disease. Researchers took skin and blood samples from 38 participants, including those with eczema, psoriasis, and healthy volunteers. The goal was to identify w…